-
1
-
-
0037168913
-
Endocrine regulation of testicular function in men: Implications for contraceptive development
-
Amory JK, Bremner W. Endocrine regulation of testicular function in men: implications for contraceptive development. MolCell Endocrinol 2002; 186:205-209.
-
(2002)
MolCell Endocrinol
, vol.186
, pp. 205-209
-
-
Amory, J.K.1
Bremner, W.2
-
3
-
-
0018001437
-
Current efforts to develop male hormonal contraception
-
Schearer SB. Current efforts to develop male hormonal contraception. Stud Fam Plann 1978; 9:229-231.
-
(1978)
Stud Fam Plann
, vol.9
, pp. 229-231
-
-
Schearer, S.B.1
-
6
-
-
0018240518
-
Clinical trial with testosterone undecanoate for male fertility control
-
Nieschlag E, Hoogen H, Bolk M, et al. Clinical trial with testosterone undecanoate for male fertility control. Contraception 1978; 18:607-614. (Pubitemid 9098602)
-
(1978)
Contraception
, vol.18
, Issue.6
, pp. 607-614
-
-
Nieschlag, E.1
Hoogen, H.2
Boelk, M.3
-
7
-
-
0017586302
-
Effect of chronic administration of testosterone enanthate on sperm production and plasma testosterone, follicle-stimulating hormone, and luteinizing hormone levels: A preliminary evaluation of a possible male contraceptive
-
Steinberger E, Smith KD. Effect of chronic administration of testosterone enanthate on sperm production and plasma testosterone, follicle-stimulating hormone, and luteinizing hormone levels: a preliminary evaluation of a possible male contraceptive. Fertil Steril 1977; 28:1320-1328.
-
(1977)
Fertil Steril
, vol.28
, pp. 1320-1328
-
-
Steinberger, E.1
Smith, K.D.2
-
8
-
-
0017730253
-
Testosterone enanthate a possible reversible male contraceptive
-
Steinberger E, Smith KD. Testosterone enanthate a possible reversible male contraceptive. Contraception 1977; 16:261-268.
-
(1977)
Contraception
, vol.16
, pp. 261-268
-
-
Steinberger, E.1
Smith, K.D.2
-
9
-
-
0025066149
-
World health organization task force on methods for the regulation of male fertility
-
World Health Organization Task Force on methods for the regulation of male f. Contraceptive efficacy of testosterone-induced azoospermia in normal men
-
World Health Organization Task Force on methods for the regulation of male f. Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility. Lancet 1990; 336:955-959.
-
(1990)
Lancet
, vol.336
, pp. 955-959
-
-
-
10
-
-
0029960780
-
World health organization task force on methods for the regulation of male f. contraceptive efficacy of testosterone-induced azoospermia and oligozoos-permia in normal men
-
World Health Organization Task Force on methods for the regulation of male f. Contraceptive efficacy of testosterone-induced azoospermia and oligozoos-permia in normal men. Fertil Steril 1996; 65:821-829.
-
(1996)
Fertil Steril
, vol.65
, pp. 821-829
-
-
-
11
-
-
0347627641
-
Use of progestins in male contraception
-
Nieschlag E, Zitzmann M, Kamischke A. Use of progestins in male contraception. Steroids 2003; 68 (10-13):965-972.
-
(2003)
Steroids
, vol.68
, Issue.10-13
, pp. 965-972
-
-
Nieschlag, E.1
Zitzmann, M.2
Kamischke, A.3
-
12
-
-
1642502519
-
A review of androgen-progestin regimens for male contraception
-
Meriggiola MC, Farley TM, Mbizvo MT. A review of androgen-progestin regimens for male contraception. J Androl 2003; 24:466-483.
-
(2003)
J Androl
, vol.24
, pp. 466-483
-
-
Meriggiola, M.C.1
Farley, T.M.2
Mbizvo, M.T.3
-
13
-
-
0021804961
-
Does constant infusion of gonadotropin-releasing hormone agonist lead to greater suppression of gonadal function in man than its intermittent administration?
-
Bhasin S, Steiner B, Swerdloff R. Does constant infusion of gonadotropin-releasing hormone agonist lead to greater suppression of gonadal function in man than its intermittent administration? Fertil Steril 1985; 44:96-101.
-
(1985)
Fertil Steril
, vol.44
, pp. 96-101
-
-
Bhasin, S.1
Steiner, B.2
Swerdloff, R.3
-
14
-
-
0021827041
-
Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen
-
Bhasin S, Heber D, Steiner BS, et al. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen. J Clin Endocrinol Metab 1985; 60:998-1003. (Pubitemid 15085135)
-
(1985)
Journal of Clinical Endocrinology and Metabolism
, vol.60
, Issue.5
, pp. 998-1003
-
-
Bhasin, S.1
Heber, D.2
Steiner, B.S.3
-
15
-
-
0024533172
-
Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men
-
Pavlou SN, Wakefield G, Schlechter NL, et al. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men. J Clin Endocrinol Metab 1989; 68:446-454.
-
(1989)
J Clin Endocrinol Metab
, vol.68
, pp. 446-454
-
-
Pavlou, S.N.1
Wakefield, G.2
Schlechter, N.L.3
-
16
-
-
0023220683
-
Suppression of pituitary-gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal men
-
Pavlou SN, Wakefield GB, Island DP, et al. Suppression of pituitary-gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal men. J Clin Endocrinol Metab 1987; 64:931-936.
-
(1987)
J Clin Endocrinol Metab
, vol.64
, pp. 931-936
-
-
Pavlou, S.N.1
Wakefield, G.B.2
Island, D.P.3
-
17
-
-
0031741889
-
Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone
-
Swerdloff RS, Bagatell CJ, Wang C, et al. Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone. J Clin Endocrinol Metab 1998; 83:3527-3533.
-
(1998)
J Clin Endocrinol Metab
, vol.83
, pp. 3527-3533
-
-
Swerdloff, R.S.1
Bagatell, C.J.2
Wang, C.3
-
18
-
-
0027250374
-
Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens
-
Bagatell CJ, Matsumoto AM, Christensen RB, et al. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens. J Clin Endocrinol Metab 1993; 77:427-432.
-
(1993)
J Clin Endocrinol Metab
, vol.77
, pp. 427-432
-
-
Bagatell, C.J.1
Matsumoto, A.M.2
Christensen, R.B.3
-
19
-
-
32544447882
-
Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: Comparison between Chinese and non-Chinese men
-
Wang C, Wang XH, Nelson AL, et al. Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: comparison between Chinese and non-Chinese men. J Clin Endocrinol Metab 2006; 91:460-470.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 460-470
-
-
Wang, C.1
Wang, X.H.2
Nelson, A.L.3
-
20
-
-
0030050344
-
Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: A promising male contraceptive approach
-
Bebb RA, Anawalt BD, Christensen RB, et al. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach. J Clin Endocrinol Metab 1996; 81:757-762.
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 757-762
-
-
Bebb, R.A.1
Anawalt, B.D.2
Christensen, R.B.3
-
21
-
-
0032902148
-
Oral progestogen combined with testosterone as a potential male contraceptive: Additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism
-
Wu FC, Balasubramanian R, Mulders TM, Coelingh-Bennink HJ. Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism. J Clin Endocrinol Metab 1999; 84:112-122.
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 112-122
-
-
Wu, F.C.1
Balasubramanian, R.2
Mulders, T.M.3
Coelingh-Bennink, H.J.4
-
22
-
-
0036171527
-
An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable nor-ethisterone preparations
-
Kamischke A, Heuermann T, Kruger K, et al. An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable nor-ethisterone preparations. J Clin Endocrinol Metab 2002; 87:530-539.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 530-539
-
-
Kamischke, A.1
Heuermann, T.2
Kruger, K.3
-
23
-
-
0029847002
-
Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot
-
Handelsman DJ, Conway AJ, Howe CJ, et al. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot. J Clin Endocrinol Metab 1996; 81:4113-4121.
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 4113-4121
-
-
Handelsman, D.J.1
Conway, A.J.2
Howe, C.J.3
-
24
-
-
0036348463
-
Levonorgestrel implants (Norplant II) for male contraception clinical trials: Combination with transdermal and injectable testosterone
-
Gonzalo ITG, Swerdloff RS, Nelson AL, et al. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone. J Clin Endocrinol Metab 2002; 87:3562-3572.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 3562-3572
-
-
Gonzalo, I.T.G.1
Swerdloff, R.S.2
Nelson, A.L.3
-
25
-
-
0242383404
-
Contraceptive efficacy of a depot progestin and androgen combination in men
-
Turner L, Conway AJ, Jimenez M, et al. Contraceptive efficacy of a depot progestin and androgen combination in men. J Clin Endocrinol Metab 2003; 88:4659-4667.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 4659-4667
-
-
Turner, L.1
Conway, A.J.2
Jimenez, M.3
-
26
-
-
0037326027
-
A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men
-
Gu YQ, Wang XH, Xu D, et al. A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men. J Clin Endocrinol Metab 2003; 88:562-568.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 562-568
-
-
Gu, Y.Q.1
Wang, X.H.2
Xu, D.3
-
27
-
-
47549091001
-
Male hormonal contraception: A double-blind, placebo-controlled study
-
Mommers E, Kersemaekers WM, Elliesen J, et al. Male hormonal contraception: a double-blind, placebo-controlled study. J Clin Endocrinol Metab 2008; 93:2572-2580.
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 2572-2580
-
-
Mommers, E.1
Kersemaekers, W.M.2
Elliesen, J.3
-
28
-
-
67650224522
-
Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men
-
Mahabadi V, Amory JK, Swerdloff RS, et al. Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men. J Clin Endocrinol Metab 2009; 94:2313-2320.
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 2313-2320
-
-
Mahabadi, V.1
Amory, J.K.2
Swerdloff, R.S.3
-
29
-
-
66749093001
-
Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men
-
Gu Y, Liang X, Wu W, et al. Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men. J Clin Endocrinol Metab 2009; 94:1910-1915.
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 1910-1915
-
-
Gu, Y.1
Liang, X.2
Wu, W.3
-
30
-
-
43249103371
-
Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: An integrated analysis
-
Liu PY, Swerdloff RS, Anawalt BD, et al. Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis. J Clin Endocrinol Metab 2008; 93:1774-1783.
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 1774-1783
-
-
Liu, P.Y.1
Swerdloff, R.S.2
Anawalt, B.D.3
-
31
-
-
2942640232
-
Testosterone metabolic clearance and production rates determined by stable isotope dilution/tandem mass spectrometry in normal men: Influence of ethnicity and age
-
Wang C, Catlin DH, Starcevic B, et al. Testosterone metabolic clearance and production rates determined by stable isotope dilution/tandem mass spectrometry in normal men: influence of ethnicity and age. J Clin Endocrinol Metab 2004; 89:2936-2941.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 2936-2941
-
-
Wang, C.1
Catlin, D.H.2
Starcevic, B.3
-
32
-
-
0031732511
-
Comparative rates of androgen production and metabolism in Caucasian and Chinese subjects
-
Santner SJ, Albertson B, Zhang GY, et al. Comparative rates of androgen production and metabolism in Caucasian and Chinese subjects. J Clin Endocrinol Metab 1998; 83:2104-2109.
-
(1998)
J Clin Endocrinol Metab
, vol.83
, pp. 2104-2109
-
-
Santner, S.J.1
Albertson, B.2
Zhang, G.Y.3
-
33
-
-
0028846963
-
Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada
-
Wu AH, Whittemore AS, Kolonel LN, et al. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev 1995; 4:735-741.
-
(1995)
Cancer Epidemiol Biomarkers Prev
, vol.4
, pp. 735-741
-
-
Wu, A.H.1
Whittemore, A.S.2
Kolonel, L.N.3
-
34
-
-
0026553251
-
5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males
-
Ross RK, Bernstein L, Lobo RA, et al. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 1992; 339:887-889.
-
(1992)
Lancet
, vol.339
, pp. 887-889
-
-
Ross, R.K.1
Bernstein, L.2
Lobo, R.A.3
-
35
-
-
0025882885
-
Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects
-
Lookingbill DP, Demers LM, Wang C, et al. Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects. J Clin Endocrinol Metab 1991; 72:1242-1248.
-
(1991)
J Clin Endocrinol Metab
, vol.72
, pp. 1242-1248
-
-
Lookingbill, D.P.1
Demers, L.M.2
Wang, C.3
-
36
-
-
21044438748
-
Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression
-
Coviello AD, Matsumoto AM, Bremner WJ, et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab 2005; 90:2595-2602.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 2595-2602
-
-
Coviello, A.D.1
Matsumoto, A.M.2
Bremner, W.J.3
-
37
-
-
0031791243
-
Graded testosterone infusions distinguish gonadotropin negative-feedback responsiveness in Asian and white men: A Clinical Research Center study
-
Wang C, Berman NG, Veldhuis JD, et al. Graded testosterone infusions distinguish gonadotropin negative-feedback responsiveness in Asian and white men: a Clinical Research Center study. J Clin Endocrinol Metab 1998; 83:870-876.
-
(1998)
J Clin Endocrinol Metab
, vol.83
, pp. 870-876
-
-
Wang, C.1
Berman, N.G.2
Veldhuis, J.D.3
-
38
-
-
14444284368
-
Spontaneous germ cell apoptosis in humans: Evidence for ethnic differences in the susceptibility of germ cells to programmed cell death
-
Hikim AP, Wang C, Lue Y, et al. Spontaneous germ cell apoptosis in humans: evidence for ethnic differences in the susceptibility of germ cells to programmed cell death. J Clin Endocrinol Metab 1998; 83:152-156.
-
(1998)
J Clin Endocrinol Metab
, vol.83
, pp. 152-156
-
-
Hikim, A.P.1
Wang, C.2
Lue, Y.3
-
39
-
-
33646153302
-
Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: An integrated analysis
-
Liu PY, Swerdloff RS, Christenson PD, et al. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet 2006; 367:1412-1420.
-
(2006)
Lancet
, vol.367
, pp. 1412-1420
-
-
Liu, P.Y.1
Swerdloff, R.S.2
Christenson, P.D.3
-
40
-
-
0020202095
-
Hormonal contraception for men: Acceptability and effects on sexuality
-
Planning WHOTFoPRiF
-
Planning WHOTFoPRiF. Hormonal contraception for men: acceptability and effects on sexuality. Stud Fam Plann 1982; 13:328-342.
-
(1982)
Stud Fam Plann
, vol.13
, pp. 328-342
-
-
-
41
-
-
0034011741
-
Potential impact of hormonal male contraception: Cross-cultural implications for development of novel preparations
-
Martin CW, Anderson RA, Cheng L, et al. Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations. Hum Reprod 2000; 15:637-645.
-
(2000)
Hum Reprod
, vol.15
, pp. 637-645
-
-
Martin, C.W.1
Anderson, R.A.2
Cheng, L.3
-
42
-
-
0034053261
-
Would women trust their partners to use a male pill?
-
Glasier AF, Anakwe R, Everington D, et al. Would women trust their partners to use a male pill? Hum Reprod 2000; 15:646-649.
-
(2000)
Hum Reprod
, vol.15
, pp. 646-649
-
-
Glasier, A.F.1
Anakwe, R.2
Everington, D.3
-
43
-
-
14044262293
-
Attitudes toward male fertility control: Results of a multinational survey on four continents
-
Heinemann K, Saad F, Wiesemes M, et al. Attitudes toward male fertility control: results of a multinational survey on four continents. Hum Reprod 2005; 20:549-556.
-
(2005)
Hum Reprod
, vol.20
, pp. 549-556
-
-
Heinemann, K.1
Saad, F.2
Wiesemes, M.3
-
44
-
-
33746457360
-
Azoospermia: Virtual reality or possible to quantify?
-
Cooper TG, Hellenkemper B, Jonckheere J, et al. Azoospermia: virtual reality or possible to quantify? J Androl 2006; 27:483-490.
-
(2006)
J Androl
, vol.27
, pp. 483-490
-
-
Cooper, T.G.1
Hellenkemper, B.2
Jonckheere, J.3
-
45
-
-
10744233376
-
A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men
-
von Eckardstein S, Noe G, Brache V, et al. A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men. J Clin Endocrinol Metab 2003; 88:5232-5239.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 5232-5239
-
-
Von Eckardstein, S.1
Noe, G.2
Brache, V.3
-
46
-
-
0032873583
-
Gonadotrophin and testosterone suppression by 7alpha-methyl-19- nortestosterone acetate administered by subdermal implant to healthy men
-
Noe G, Suvisaari J, Martin C, et al. Gonadotrophin and testosterone suppression by 7alpha-methyl-19-nortestosterone acetate administered by subdermal implant to healthy men. Hum Reprod 1999; 14:2200-2206.
-
(1999)
Hum Reprod
, vol.14
, pp. 2200-2206
-
-
Noe, G.1
Suvisaari, J.2
Martin, C.3
-
47
-
-
33646809681
-
Dimethandrolone undecanoate: A new potent orally active androgen with progestational activity
-
Attardi BJ, Hild SA, Reel JR. Dimethandrolone undecanoate: a new potent orally active androgen with progestational activity. Endocrinology 2006; 147:3016-3026.
-
(2006)
Endocrinology
, vol.147
, pp. 3016-3026
-
-
Attardi, B.J.1
Hild, S.A.2
Reel, J.R.3
-
48
-
-
44849091208
-
Dimethandrolone (7alpha, 11 beta-dimethyl-19-nortestosterone) and 11beta-methyl-19-nortestosterone are not converted to aromatic A-ring products in the presence of recombinant human aromatase
-
Attardi BJ, Pham TC, Radler LC, et al. Dimethandrolone (7alpha, 11 beta-dimethyl-19-nortestosterone) and 11beta-methyl-19-nortestosterone are not converted to aromatic A-ring products in the presence of recombinant human aromatase. J Steroid Biochem Mol Biol 2008; 110 (3-5):214-222.
-
(2008)
J Steroid Biochem Mol Biol
, vol.110
, Issue.3-5
, pp. 214-222
-
-
Attardi, B.J.1
Pham, T.C.2
Radler, L.C.3
-
49
-
-
67549142234
-
Nonsteroidal selective androgen receptor modulators (SARMs): Dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit
-
Mohler ML, Bohl CE, Jones A, et al. Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit. J Med Chem 2009; 52:3597-3617.
-
(2009)
J Med Chem
, vol.52
, pp. 3597-3617
-
-
Mohler, M.L.1
Bohl, C.E.2
Jones, A.3
-
50
-
-
59049096464
-
Selective androgen receptor modulators in preclinical and clinical development
-
Narayanan R, Mohler ML, Bohl CE, et al. Selective androgen receptor modulators in preclinical and clinical development. Nucl Recept Signal 2008; 6:e010.
-
(2008)
Nucl Recept Signal
, vol.6
-
-
Narayanan, R.1
Mohler, M.L.2
Bohl, C.E.3
-
51
-
-
58149473439
-
Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl- phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: A selective androgen receptor modulator for hormonal male contraception
-
Jones A, Chen J, Hwang DJ, et al. Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2- hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception. Endocrinology 2009; 150:385-395.
-
(2009)
Endocrinology
, vol.150
, pp. 385-395
-
-
Jones, A.1
Chen, J.2
Hwang, D.J.3
|